vs

Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and Johnson Controls (JCI). Click either name above to swap in a different company.

Johnson Controls is the larger business by last-quarter revenue ($5.8B vs $5.5B, roughly 1.1× Fresenius Medical Care AG). Johnson Controls runs the higher net margin — 9.0% vs 7.9%, a 1.1% gap on every dollar of revenue. On growth, Johnson Controls posted the faster year-over-year revenue change (6.8% vs -0.3%).

Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.

Johnson Controls International plc is an Irish multinational conglomerate headquartered in Cork, Ireland, that produces fire, HVAC, and security equipment for buildings. As of mid-2019, it employed 105,000 people in around 2,000 locations across six continents. In 2017 it was listed as 389th in the Fortune Global 500. It became ineligible for the Fortune 500 in subsequent years since it relocated its headquarters outside the U.S.

FMS vs JCI — Head-to-Head

Bigger by revenue
JCI
JCI
1.1× larger
JCI
$5.8B
$5.5B
FMS
Growing faster (revenue YoY)
JCI
JCI
+7.1% gap
JCI
6.8%
-0.3%
FMS
Higher net margin
JCI
JCI
1.1% more per $
JCI
9.0%
7.9%
FMS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FMS
FMS
JCI
JCI
Revenue
$5.5B
$5.8B
Net Profit
$434.2M
$524.0M
Gross Margin
27.4%
35.8%
Operating Margin
11.7%
Net Margin
7.9%
9.0%
Revenue YoY
-0.3%
6.8%
Net Profit YoY
240.4%
25.1%
EPS (diluted)
$0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FMS
FMS
JCI
JCI
Q4 25
$5.5B
$5.8B
Q3 25
$6.4B
Q2 25
$6.1B
Q1 25
$5.7B
Q4 24
$5.5B
$5.4B
Q3 24
$2.9B
Q2 24
$7.2B
Q1 24
$6.7B
Net Profit
FMS
FMS
JCI
JCI
Q4 25
$434.2M
$524.0M
Q3 25
$1.7B
Q2 25
$701.0M
Q1 25
$478.0M
Q4 24
$127.6M
$419.0M
Q3 24
$633.0M
Q2 24
$975.0M
Q1 24
$-277.0M
Gross Margin
FMS
FMS
JCI
JCI
Q4 25
27.4%
35.8%
Q3 25
36.5%
Q2 25
37.1%
Q1 25
36.5%
Q4 24
25.0%
35.5%
Q3 24
48.4%
Q2 24
34.4%
Q1 24
32.6%
Operating Margin
FMS
FMS
JCI
JCI
Q4 25
11.7%
Q3 25
5.5%
Q2 25
11.6%
Q1 25
8.8%
Q4 24
5.1%
7.5%
Q3 24
6.9%
Q2 24
17.7%
Q1 24
-5.4%
Net Margin
FMS
FMS
JCI
JCI
Q4 25
7.9%
9.0%
Q3 25
26.3%
Q2 25
11.6%
Q1 25
8.4%
Q4 24
2.3%
7.7%
Q3 24
21.6%
Q2 24
13.5%
Q1 24
-4.1%
EPS (diluted)
FMS
FMS
JCI
JCI
Q4 25
$0.85
Q3 25
$2.61
Q2 25
$1.07
Q1 25
$0.72
Q4 24
$0.63
Q3 24
$0.93
Q2 24
$1.45
Q1 24
$-0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FMS
FMS
JCI
JCI
Cash + ST InvestmentsLiquidity on hand
$1.7B
$552.0M
Total DebtLower is stronger
$8.7B
Stockholders' EquityBook value
$15.4B
$13.2B
Total Assets
$33.5B
$38.0B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FMS
FMS
JCI
JCI
Q4 25
$1.7B
$552.0M
Q3 25
$379.0M
Q2 25
$731.0M
Q1 25
$795.0M
Q4 24
$1.3B
$1.2B
Q3 24
$606.0M
Q2 24
$862.0M
Q1 24
$843.0M
Total Debt
FMS
FMS
JCI
JCI
Q4 25
$8.7B
Q3 25
$8.6B
Q2 25
$8.4B
Q1 25
$8.2B
Q4 24
$8.6B
Q3 24
$8.0B
Q2 24
$7.9B
Q1 24
$7.3B
Stockholders' Equity
FMS
FMS
JCI
JCI
Q4 25
$15.4B
$13.2B
Q3 25
$12.9B
Q2 25
$15.8B
Q1 25
$15.8B
Q4 24
$17.0B
$15.9B
Q3 24
$16.1B
Q2 24
$16.0B
Q1 24
$15.7B
Total Assets
FMS
FMS
JCI
JCI
Q4 25
$33.5B
$38.0B
Q3 25
$37.9B
Q2 25
$43.4B
Q1 25
$42.4B
Q4 24
$36.3B
$42.1B
Q3 24
$42.7B
Q2 24
$43.3B
Q1 24
$43.5B
Debt / Equity
FMS
FMS
JCI
JCI
Q4 25
0.66×
Q3 25
0.66×
Q2 25
0.53×
Q1 25
0.52×
Q4 24
0.54×
Q3 24
0.50×
Q2 24
0.49×
Q1 24
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FMS
FMS
JCI
JCI
Operating Cash FlowLast quarter
$2.9B
$611.0M
Free Cash FlowOCF − Capex
$531.0M
FCF MarginFCF / Revenue
9.2%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
6.67×
1.17×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FMS
FMS
JCI
JCI
Q4 25
$2.9B
$611.0M
Q3 25
$968.0M
Q2 25
$787.0M
Q1 25
$550.0M
Q4 24
$2.6B
$249.0M
Q3 24
$1.4B
Q2 24
$1.0B
Q1 24
$-203.0M
Free Cash Flow
FMS
FMS
JCI
JCI
Q4 25
$531.0M
Q3 25
$838.0M
Q2 25
$693.0M
Q1 25
$456.0M
Q4 24
$133.0M
Q3 24
$1.2B
Q2 24
$922.0M
Q1 24
$-336.0M
FCF Margin
FMS
FMS
JCI
JCI
Q4 25
9.2%
Q3 25
13.0%
Q2 25
11.5%
Q1 25
8.0%
Q4 24
2.5%
Q3 24
40.4%
Q2 24
12.8%
Q1 24
-5.0%
Capex Intensity
FMS
FMS
JCI
JCI
Q4 25
1.4%
Q3 25
2.0%
Q2 25
1.6%
Q1 25
1.7%
Q4 24
2.1%
Q3 24
5.8%
Q2 24
1.4%
Q1 24
2.0%
Cash Conversion
FMS
FMS
JCI
JCI
Q4 25
6.67×
1.17×
Q3 25
0.57×
Q2 25
1.12×
Q1 25
1.15×
Q4 24
20.20×
0.59×
Q3 24
2.14×
Q2 24
1.05×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FMS
FMS

Segment breakdown not available.

JCI
JCI

Productsand Systems$3.9B67%
Services$1.9B33%

Related Comparisons